Immunovant (IMVT) Enterprise Value (2018 - 2026)
Immunovant (IMVT) posted Enterprise Value of -$902.1 million for Q1 2026, up 9.29% on a QoQ basis from -$994.5 million in Q4 2025, and down 26.35% year-over-year from -$1.2 billion in Q1 2025.
Immunovant (IMVT) Enterprise Value (2018 - 2026) Analysis & Trends
Immunovant's Enterprise Value history runs 9 years deep, the most recent figure standing at -$902.1 million for Q1 2026.
- Quarterly Enterprise Value fell 26.35% year-over-year to -$902.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$902.1 million (down 26.35% YoY) and the FY2026 annual result came in at -$902.1 million, down 26.35% from the prior year.
- Enterprise Value was -$902.1 million for Q1 2026 at Immunovant, up from -$994.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$269.9 million in Q3 2023 and bottomed at -$994.5 million in Q4 2025.
- A 5-year average of -$541.2 million and a median of -$493.8 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value jumped 45.77% — and 2025, when it plunged 165.42%.
- Immunovant's Enterprise Value stood at -$432.6 million in 2022, then slumped by 59.71% to -$690.9 million in 2023, then soared by 45.77% to -$374.7 million in 2024, then plunged by 165.42% to -$994.5 million in 2025, then increased by 9.29% to -$902.1 million in 2026.
- Business Quant data shows IMVT's Enterprise Value at -$902.1 million in Q1 2026, -$994.5 million in Q4 2025, and -$521.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - | -902.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -902.11 Mn |
| Dec 31, 2025 | -994.53 Mn |
| Sep 30, 2025 | -521.87 Mn |
| Jun 30, 2025 | -598.90 Mn |
| Mar 31, 2025 | -713.97 Mn |
| Dec 31, 2024 | -374.70 Mn |
| Sep 30, 2024 | -472.94 Mn |
| Jun 30, 2024 | -560.00 Mn |
| Mar 31, 2024 | -635.37 Mn |
| Dec 31, 2023 | -690.90 Mn |
| Sep 30, 2023 | -269.93 Mn |
| Jun 30, 2023 | -329.96 Mn |
| Mar 31, 2023 | -376.53 Mn |
| Dec 31, 2022 | -432.61 Mn |
| Sep 30, 2022 | -405.77 Mn |
| Jun 30, 2022 | -427.20 Mn |
| Mar 31, 2022 | -493.82 Mn |
| Dec 31, 2021 | -527.00 Mn |
| Sep 30, 2021 | -559.00 Mn |
| Jun 30, 2021 | -379.01 Mn |